Matches in SemOpenAlex for { <https://semopenalex.org/work/W4283327089> ?p ?o ?g. }
- W4283327089 endingPage "150" @default.
- W4283327089 startingPage "150" @default.
- W4283327089 abstract "<ns4:p>Drug repositioning and the relevance of orphan drug designation for β-thalassemia is reviewed. Drug repositioning and similar terms ('drug repurposing', 'drug reprofiling', 'drug redirecting', ‘drug rescue’, ‘drug re-tasking’ and/or 'drug rediscovery') have gained great attention, especially in the field or rare diseases (RDs), and represent relevant novel drug development strategies to be considered together with the “off-label” use of pharmaceutical products under clinical trial regimen. The most significant advantage of drug repositioning over traditional drug development is that the repositioned drug has already passed a significant number of short- and long-term toxicity tests, as well as it has already undergone pharmacokinetic and pharmacodynamic (PK/PD) studies. The established safety of repositioned drugs is known to significantly reduce the probability of project failure. Furthermore, development of repurposed drugs can shorten much of the time needed to bring a drug to market. Finally, patent filing of repurposed drugs is expected to catch the attention of pharmaceutical industries interested in the development of therapeutic protocols for RDs. Repurposed molecules that could be proposed as potential drugs for β-thalassemia, will be reported, with some of the most solid examples, including sirolimus (rapamycin) that recently has been tested in a pilot clinical trial.</ns4:p>" @default.
- W4283327089 created "2022-06-24" @default.
- W4283327089 creator A5004138315 @default.
- W4283327089 creator A5011752198 @default.
- W4283327089 creator A5019637340 @default.
- W4283327089 creator A5030568464 @default.
- W4283327089 creator A5057667251 @default.
- W4283327089 creator A5068509156 @default.
- W4283327089 date "2022-06-23" @default.
- W4283327089 modified "2023-09-23" @default.
- W4283327089 title "A Rational Approach to Drug Repositioning in β-thalassemia: Induction of Fetal Hemoglobin by Established Drugs" @default.
- W4283327089 cites W1075075767 @default.
- W4283327089 cites W1505560885 @default.
- W4283327089 cites W1678460261 @default.
- W4283327089 cites W1840928693 @default.
- W4283327089 cites W1870387638 @default.
- W4283327089 cites W1966779777 @default.
- W4283327089 cites W1970433183 @default.
- W4283327089 cites W1994566624 @default.
- W4283327089 cites W2012661184 @default.
- W4283327089 cites W2019481341 @default.
- W4283327089 cites W2028135932 @default.
- W4283327089 cites W2053127979 @default.
- W4283327089 cites W2062941476 @default.
- W4283327089 cites W2093313266 @default.
- W4283327089 cites W2143695548 @default.
- W4283327089 cites W2147028601 @default.
- W4283327089 cites W2149623095 @default.
- W4283327089 cites W2153217958 @default.
- W4283327089 cites W2166140328 @default.
- W4283327089 cites W2274632826 @default.
- W4283327089 cites W2291797353 @default.
- W4283327089 cites W2330248283 @default.
- W4283327089 cites W2332195908 @default.
- W4283327089 cites W2335456398 @default.
- W4283327089 cites W2410401934 @default.
- W4283327089 cites W2513071654 @default.
- W4283327089 cites W2753758710 @default.
- W4283327089 cites W2761623236 @default.
- W4283327089 cites W2789811792 @default.
- W4283327089 cites W2792055649 @default.
- W4283327089 cites W2800553942 @default.
- W4283327089 cites W2801518413 @default.
- W4283327089 cites W2806662900 @default.
- W4283327089 cites W2885654157 @default.
- W4283327089 cites W2889987924 @default.
- W4283327089 cites W2900131897 @default.
- W4283327089 cites W2969792377 @default.
- W4283327089 cites W3037116761 @default.
- W4283327089 cites W3042438215 @default.
- W4283327089 cites W3092016408 @default.
- W4283327089 cites W3102282020 @default.
- W4283327089 cites W3106342198 @default.
- W4283327089 cites W3138399121 @default.
- W4283327089 cites W3143623064 @default.
- W4283327089 cites W3147962292 @default.
- W4283327089 cites W3164865284 @default.
- W4283327089 cites W3167044781 @default.
- W4283327089 cites W3171960525 @default.
- W4283327089 cites W3181131588 @default.
- W4283327089 cites W3183351471 @default.
- W4283327089 cites W3187992181 @default.
- W4283327089 cites W3195310830 @default.
- W4283327089 cites W3199000899 @default.
- W4283327089 cites W3211148609 @default.
- W4283327089 cites W4200061838 @default.
- W4283327089 cites W4200101171 @default.
- W4283327089 cites W4206279393 @default.
- W4283327089 cites W4206317456 @default.
- W4283327089 cites W4211214940 @default.
- W4283327089 cites W4213288371 @default.
- W4283327089 cites W4224995847 @default.
- W4283327089 cites W4233789535 @default.
- W4283327089 cites W4235541419 @default.
- W4283327089 cites W4243712789 @default.
- W4283327089 doi "https://doi.org/10.12688/wellcomeopenres.17845.2" @default.
- W4283327089 hasPublicationYear "2022" @default.
- W4283327089 type Work @default.
- W4283327089 citedByCount "1" @default.
- W4283327089 countsByYear W42833270892023 @default.
- W4283327089 crossrefType "journal-article" @default.
- W4283327089 hasAuthorship W4283327089A5004138315 @default.
- W4283327089 hasAuthorship W4283327089A5011752198 @default.
- W4283327089 hasAuthorship W4283327089A5019637340 @default.
- W4283327089 hasAuthorship W4283327089A5030568464 @default.
- W4283327089 hasAuthorship W4283327089A5057667251 @default.
- W4283327089 hasAuthorship W4283327089A5068509156 @default.
- W4283327089 hasBestOaLocation W42833270891 @default.
- W4283327089 hasConcept C103637391 @default.
- W4283327089 hasConcept C111113717 @default.
- W4283327089 hasConcept C112705442 @default.
- W4283327089 hasConcept C177713679 @default.
- W4283327089 hasConcept C2777494893 @default.
- W4283327089 hasConcept C2780035454 @default.
- W4283327089 hasConcept C64903051 @default.
- W4283327089 hasConcept C71924100 @default.
- W4283327089 hasConcept C98274493 @default.
- W4283327089 hasConceptScore W4283327089C103637391 @default.